rs150547672

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_000169.3(GLA):​c.8T>C​(p.Leu3Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,208,132 control chromosomes in the GnomAD database, including 2 homozygotes. There are 42 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L3V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00086 ( 1 hom., 26 hem., cov: 23)
Exomes 𝑓: 0.000087 ( 1 hom. 16 hem. )

Consequence

GLA
NM_000169.3 missense

Scores

3
3
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:2B:14O:1

Conservation

PhyloP100: 0.323

Publications

6 publications found
Variant links:
Genes affected
GLA (HGNC:4296): (galactosidase alpha) This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
RPL36A-HNRNPH2 (HGNC:48349): (RPL36A-HNRNPH2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring ribosomal protein L36a and heterogeneous nuclear ribonucleoprotein H2 (H') genes on chromosome X. The read-through transcript produces a protein with similarity to the protein encoded by the upstream locus, ribosomal protein L36a. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jan 2011]
HNRNPH2 (HGNC:5042): (heterogeneous nuclear ribonucleoprotein H2) This gene belongs to the subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has three repeats of quasi-RRM domains that binds to RNAs. It is very similar to the family member HNRPH1. This gene is thought to be involved in Fabray disease and X-linked agammaglobulinemia phenotype. Alternative splicing results in multiple transcript variants encoding the same protein. Read-through transcription between this locus and the ribosomal protein L36a gene has been observed. [provided by RefSeq, Jan 2011]
HNRNPH2 Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, X-linked, syndromic, Bain type
    Inheritance: XL Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a signal_peptide (size 30) in uniprot entity AGAL_HUMAN there are 16 pathogenic changes around while only 5 benign (76%) in NM_000169.3
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 218 curated pathogenic missense variants (we use a threshold of 10). The gene has 17 curated benign missense variants. Gene score misZ: 1.8759 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to Fabry disease.
BP4
Computational evidence support a benign effect (MetaRNN=0.024546802).
BP6
Variant X-101407896-A-G is Benign according to our data. Variant chrX-101407896-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 42464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000864 (97/112310) while in subpopulation AFR AF = 0.00301 (93/30907). AF 95% confidence interval is 0.00251. There are 1 homozygotes in GnomAd4. There are 26 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 26 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000169.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLA
NM_000169.3
MANE Select
c.8T>Cp.Leu3Pro
missense
Exon 1 of 7NP_000160.1P06280
GLA
NM_001406747.1
c.8T>Cp.Leu3Pro
missense
Exon 1 of 8NP_001393676.1A0A3B3IUC4
GLA
NM_001406748.1
c.8T>Cp.Leu3Pro
missense
Exon 1 of 6NP_001393677.1A0A6Q8PHD1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLA
ENST00000218516.4
TSL:1 MANE Select
c.8T>Cp.Leu3Pro
missense
Exon 1 of 7ENSP00000218516.4P06280
RPL36A-HNRNPH2
ENST00000409170.3
TSL:4
c.301-4040A>G
intron
N/AENSP00000386655.4H7BZ11
GLA
ENST00000649178.1
c.8T>Cp.Leu3Pro
missense
Exon 1 of 8ENSP00000498186.1A0A3B3IUC4

Frequencies

GnomAD3 genomes
AF:
0.000855
AC:
96
AN:
112254
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00298
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000281
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000664
GnomAD2 exomes
AF:
0.000235
AC:
43
AN:
183334
AF XY:
0.0000885
show subpopulations
Gnomad AFR exome
AF:
0.00319
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000867
AC:
95
AN:
1095822
Hom.:
1
Cov.:
31
AF XY:
0.0000443
AC XY:
16
AN XY:
361252
show subpopulations
African (AFR)
AF:
0.00323
AC:
85
AN:
26336
American (AMR)
AF:
0.0000852
AC:
3
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19370
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30199
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54057
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40529
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3998
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
840116
Other (OTH)
AF:
0.000152
AC:
7
AN:
46015
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000864
AC:
97
AN:
112310
Hom.:
1
Cov.:
23
AF XY:
0.000754
AC XY:
26
AN XY:
34476
show subpopulations
African (AFR)
AF:
0.00301
AC:
93
AN:
30907
American (AMR)
AF:
0.000281
AC:
3
AN:
10685
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2655
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3548
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2696
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53239
Other (OTH)
AF:
0.000655
AC:
1
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000324
Hom.:
15
Bravo
AF:
0.00115
ESP6500AA
AF:
0.00417
AC:
16
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000247
AC:
30

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
6
Fabry disease (8)
-
-
4
not specified (4)
-
-
1
Cardiomyopathy (1)
-
-
1
Cardiovascular phenotype (1)
-
-
1
GLA-related disorder (1)
-
-
1
not provided (1)
-
-
-
Migalastat response (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
CardioboostCm
Benign
0.051
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.44
T
M_CAP
Pathogenic
0.96
D
MetaRNN
Benign
0.025
T
MetaSVM
Pathogenic
2.0
D
MutationAssessor
Benign
1.1
L
PhyloP100
0.32
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.64
N
REVEL
Benign
0.22
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0040
D
Polyphen
0.0030
B
Vest4
0.76
MVP
0.82
MPC
2.2
ClinPred
0.12
T
GERP RS
1.3
PromoterAI
0.028
Neutral
Varity_R
0.25
gMVP
0.92
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150547672; hg19: chrX-100662884; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.